Jounce Therapeutics, Inc.

UBS Group AG

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/12/2023

Shares

21,031

Value ($000)

39

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/12/2023	39	0.0%	21,031	3/31/2023
2022 Q4	2/8/2023	13	0.0%	11,827	12/31/2022
2022 Q3	11/10/2022	1	0.0%	231	9/30/2022
2022 Q2	8/10/2022	82	0.0%	26,787	6/30/2022
2022 Q1	5/16/2022	85	0.0%	12,587	3/31/2022
2021 Q4	2/14/2022	193	0.0%	23,077	12/31/2021
2021 Q3	11/15/2021	84	0.0%	11,324	9/30/2021
2021 Q2	8/13/2021	125	0.0%	18,321	6/30/2021
2021 Q1	5/12/2021	199	0.0%	19,383	3/31/2021
2020 Q4	2/11/2021	29	0.0%	4,103	12/31/2020
2020 Q3	11/12/2020	6	0.0%	769	9/30/2020
2020 Q2	7/31/2020	38	0.0%	5,460	6/30/2020
2020 Q1	5/1/2020	69	0.0%	14,602	3/31/2020
2019 Q4	2/14/2020	178	0.0%	20,395	12/31/2019